Envestnet Asset Management Inc Royalty Pharma PLC Transaction History

Envestnet Asset Management Inc

$324 Billion
Q3 2025

A detailed history of Envestnet Asset Management Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Envestnet Asset Management Inc holds 437,451 shares of RPRX stock, worth $17.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

437,451

Previous 97,612 348.15%

Holding current value

$17.1 Million

Previous $3.52 Million 338.94%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	BUY	$34.9 - $37.91 $11.9 Million - $12.9 Million	339,839 Added 348.15%	437,451 $15.4 Million
Q2 2025 Jul 31, 2025	SELL	$30.85 - $36.14 $192,812 - $225,875	-6,250 Reduced 6.02%	97,612 $3.52 Million
Q1 2025 Apr 29, 2025	BUY	$25.75 - $33.86 $955,376 - $1.26 Million	37,102 Added 55.58%	103,862 $3.23 Million
Q4 2024 Feb 12, 2025	SELL	$24.28 - $28.39 $18,525 - $21,661	-763 Reduced 1.13%	66,760 $1.7 Million
Q3 2024 Nov 06, 2024	SELL	$25.63 - $29.27 $233,284 - $266,415	-9,102 Reduced 11.88%	67,523 $1.91 Million

Q2 2024 Aug 08, 2024	SELL	$26.26 - $29.9 $318,113 - $362,208	-12,114 Reduced 13.65%	76,625 $2.02 Million
Q1 2024 May 13, 2024	BUY	$27.46 - $31.33 $1.35 Million - $1.54 Million	49,256 Added 124.75%	88,739 $2.7 Million
Q4 2023 Feb 13, 2024	BUY	$26.21 - $29.22 $475,423 - $530,021	18,139 Added 84.98%	39,483 $1.11 Million
Q3 2023 Nov 13, 2023	BUY	$26.26 - $31.38 $153,831 - $183,824	5,858 Added 37.83%	21,344 $579,000
Q2 2023 Aug 04, 2023	SELL	$29.6 - $36.56 $10,034 - $12,393	-339 Reduced 2.14%	15,486 $476,000
Q1 2023 May 11, 2023	BUY	$32.77 - $39.4 $95,000 - $114,220	2,899 Added 22.43%	15,825 $570,000
Q4 2022 Feb 07, 2023	BUY	$39.17 - $44.04 $16,764 - $18,849	428 Added 3.42%	12,926 $510,000
Q3 2022 Nov 10, 2022	BUY	$39.88 - $44.65 $94,555 - $105,865	2,371 Added 23.41%	12,498 $502,000
Q2 2022 Aug 03, 2022	BUY	$37.53 - $44.22 $60,160 - $70,884	1,603 Added 18.81%	10,127 $426,000
Q1 2022 May 04, 2022	BUY	$37.46 - $42.44 $81,512 - $92,349	2,176 Added 34.28%	8,524 $332,000
Q4 2021 Feb 04, 2022	BUY	$35.17 - $42.48 $223,259 - $269,663	6,348 New	6,348 $253,000

Others Institutions Holding RPRX

# of Institutions

535

Shares Held

303M

Call Options Held

1.34M

Put Options Held

252K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $17.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Royalty Pharma PLC Transaction History